Ginsenoside Rh4

CAS : 174721-08-5

Ref. 3D-OG31928

Informations sur le produit

• Nom: Ginsenoside Rh4
• Synonymes: (3β,6α,12β,20E)-3,12-Dihydroxydammara-20(22),24-dien-6-yl β-<span class="text-smallcaps">D</span>-glucopyranoside, Ginsenoside Rh₄, beta-D-glucopyranoside, (3beta,6alpha,12beta,20E)-3,12-dihydroxydammara-20(22),24-dien-6-yl, β-<span class="text-smallcaps">D</span>-Glucopyranoside, (3β,6α,12β,20E)-3,12-dihydroxydammara-20(22),24-dien-6-yl

Description

Ginsenoside Rh4 is a ginseng saponin with anti-diabetic properties. It inhibits the mitochondrial membrane potential and oxidative injury in human leukemia cells. Ginsenoside Rh4 has been shown to induce autophagy, which is a process that helps eliminate damaged or unnecessary cellular components. Ginsenoside Rh4 also reduces the release of reactive oxygen species (ROS), which may be due to its ability to inhibit Toll-like receptor 4 (TLR4) signaling pathways. Ginsenoside Rh4 has potential as a drug target for cancer treatment due to its ability to inhibit polymerase chain reaction (PCR) activity and reduce tumor size in mice models.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 620.86 g/mol
• Formule: C₃₆H₆₀O₈
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder